202 related articles for article (PubMed ID: 21678351)
1. Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment.
Kew F; Galaal K; Bryant A; Naik R
Cochrane Database Syst Rev; 2011 Jun; (6):CD006119. PubMed ID: 21678351
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment.
Clarke T; Galaal K; Bryant A; Naik R
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD006119. PubMed ID: 25198378
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment.
Zachou G; El-Khouly F; Dilley J
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD006119. PubMed ID: 37650760
[TBL] [Abstract][Full Text] [Related]
4. Surgical cytoreduction for recurrent epithelial ovarian cancer.
Al Rawahi T; Lopes AD; Bristow RE; Bryant A; Elattar A; Chattopadhyay S; Galaal K
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD008765. PubMed ID: 23450588
[TBL] [Abstract][Full Text] [Related]
5. Optimal primary surgical treatment for advanced epithelial ovarian cancer.
Elattar A; Bryant A; Winter-Roach BA; Hatem M; Naik R
Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD007565. PubMed ID: 21833960
[TBL] [Abstract][Full Text] [Related]
6. Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.
Ang C; Chan KK; Bryant A; Naik R; Dickinson HO
Cochrane Database Syst Rev; 2011 Apr; (4):CD007697. PubMed ID: 21491400
[TBL] [Abstract][Full Text] [Related]
7. Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.
Wuntakal R; Seshadri S; Montes A; Lane G
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD011322. PubMed ID: 27356090
[TBL] [Abstract][Full Text] [Related]
8. Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.
Lawal AO; Musekiwa A; Grobler L
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009620. PubMed ID: 23740789
[TBL] [Abstract][Full Text] [Related]
9. Antigen-specific active immunotherapy for ovarian cancer.
Leffers N; Daemen T; Helfrich W; Boezen HM; Cohlen BJ; Melief CJ; Nijman HW
Cochrane Database Syst Rev; 2014 Sep; (9):CD007287. PubMed ID: 25229990
[TBL] [Abstract][Full Text] [Related]
10. Interventions for the treatment of borderline ovarian tumours.
Faluyi O; Mackean M; Gourley C; Bryant A; Dickinson HO
Cochrane Database Syst Rev; 2010 Sep; 2010(9):CD007696. PubMed ID: 20824864
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Winter-Roach BA; Kitchener HC; Dickinson HO
Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
[TBL] [Abstract][Full Text] [Related]
12. Centralisation of services for gynaecological cancer.
Woo YL; Kyrgiou M; Bryant A; Everett T; Dickinson HO
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD007945. PubMed ID: 22419327
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor blockers for the treatment of ovarian cancer.
Haldar K; Gaitskell K; Bryant A; Nicum S; Kehoe S; Morrison J
Cochrane Database Syst Rev; 2011 Oct; (10):CD007927. PubMed ID: 21975775
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Winter-Roach BA; Kitchener HC; Dickinson HO
Cochrane Database Syst Rev; 2009 Jul; (3):CD004706. PubMed ID: 19588360
[TBL] [Abstract][Full Text] [Related]
15. Chemoradiation for advanced primary vulval cancer.
Shylasree TS; Bryant A; Howells RE
Cochrane Database Syst Rev; 2011 Apr; 2011(4):CD003752. PubMed ID: 21491387
[TBL] [Abstract][Full Text] [Related]
16. Follow-up protocols for women with cervical cancer after primary treatment.
Lanceley A; Fiander A; McCormack M; Bryant A
Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD008767. PubMed ID: 24277645
[TBL] [Abstract][Full Text] [Related]
17. Palliative surgery versus medical management for bowel obstruction in ovarian cancer.
Kucukmetin A; Naik R; Galaal K; Bryant A; Dickinson HO
Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD007792. PubMed ID: 20614464
[TBL] [Abstract][Full Text] [Related]
18. Is immediate imaging important in managing low back pain?
Andersen JC
J Athl Train; 2011; 46(1):99-102. PubMed ID: 21214357
[TBL] [Abstract][Full Text] [Related]
19. Interval debulking surgery for advanced epithelial ovarian cancer.
Tangjitgamol S; Manusirivithaya S; Laopaiboon M; Lumbiganon P; Bryant A
Cochrane Database Syst Rev; 2010 Oct; (10):CD006014. PubMed ID: 20927744
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer.
Galaal K; Naik R; Bristow RE; Patel A; Bryant A; Dickinson HO
Cochrane Database Syst Rev; 2010 Jun; 2010(6):CD007822. PubMed ID: 20556785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
